Prosaposin

Alternative Names

  • PSAP
  • Saposin A
  • SAPA
  • Saposin B
  • SAPB
  • Saposin C
  • SAPC
  • Saposin D
  • SAPD
  • Sphingolipid Activator Protein 1
  • SAP1
  • Sphingolipid Activator Protein 2
  • SAP2
Back to search Result
OMIM Number

176801

NCBI Gene ID

5660

Uniprot ID

P07602

Length

34,954 bases

No. of Exons

15

No. of isoforms

3

Protein Name

Prosaposin

Molecular Mass

58113 Da

Amino Acid Count

524

Genomic Location

chr10:71,816,297-71,851,250

Gene Map Locus
10q22.1

Description

This gene encodes a highly conserved preproprotein that is proteolytically processed to generate four main cleavage products including saposins A, B, C, and D. Each domain of the precursor protein is approximately 80 amino acid residues long with nearly identical placement of cysteine residues and glycosylation sites. Saposins A-D localize primarily to the lysosomal compartment where they facilitate the catabolism of glycosphingolipids with short oligosaccharide groups. The precursor protein exists both as a secretory protein and as an integral membrane protein and has neurotrophic activities. Mutations in this gene have been associated with Gaucher disease and metachromatic leukodystrophy. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]

Molecular Genetics

The Prosaposin gene, located on the long arm of chromosome 10, is 35 kb long.  Its coding sequence consists of 15 exons.  The protein encoded by the PSAP gene is made up of 524 amino acids and is about 58 kDa in size.  So far, about seven mutations in PSAP (most of them being homozygous, single nucleotide substitutions) have been associated with metachromatic leukodystrophy.  The mutation C241S has been reported in several Arab metachromatic leukodystrophy patients.  

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_002778.4:c.1005+1G>AUnited Arab EmiratesNC_000010.11:g.71820239C>TPathogenicLikely PathogenicGaucher Disease, Atypical, due to Saposin C DeficiencyNG_009301.1:g.36087G>A; NM_002778.4:c.1005+1G>A; NP_002769.1:p.?1133657441330309

Other Reports

Arab

Information to be added soon. 

Saudi Arabia

Al-Hassnan et al. (2009) reported on nine patients that were sphingolipid activator protein B deficient. The individuals were from four unrelated consanguineous Saudi families belonging to different tribes.  While two of the patients were asymptomatic, the remaining seven had symptoms ranging from neuroregression, walking difficulties and dysarthria to elevated urine levels of sulfatide.  Genetic analysis of the PSAP gene revealed a homozygous mutation (c.722G>C) resulting in a C241S substitution in all nine patients.  The parents in each family were found to be heterozygous for the mutation.  It was speculated that C241S may be a founder mutation in Arabs.  

© CAGS 2024. All rights reserved.